Related Experiment Video

Updated: Aug 19, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction

Chengchen Lufei1, Jing Ma, Guochang Huang

  • 1Institute of Molecular and Cell Biology, 30 Medical Drive, Singapore 117609.

The EMBO Journal
|March 12, 2003
PubMed

Insights

GRIM-19 interacts with Signal transducer and activator of transcription 3 (Stat3), inhibiting its nuclear translocation and transcriptional activity. This finding identifies GRIM-19 as a novel negative regulator of Stat3, impacting cell growth and cancer progression.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Signal transducer and activator of transcription 3 (Stat3) is a key transcription factor regulating cell growth, survival, and transformation.
  • Constitutive activation of Stat3 is implicated in the development and progression of various cancers.
  • Identifying Stat3 regulators is crucial for understanding cancer mechanisms and developing targeted therapies.

Purpose of the Study:

  • To identify novel regulators of Signal transducer and activator of transcription 3 (Stat3).
  • To investigate the interaction between GRIM-19 and Stat3.
  • To elucidate the functional consequences of this interaction on Stat3 activity and cell behavior.

Main Methods:

  • Yeast two-hybrid screening to identify Stat3 interacting proteins.
  • Co-immunoprecipitation and immunofluorescence assays to confirm and localize the GRIM-19/Stat3 interaction.
  • Reporter gene assays to assess Stat3 transcriptional activity.
  • Cell proliferation assays in cancer cell lines.

Main Results:

  • GRIM-19 was identified as a Stat3-interacting protein through yeast two-hybrid screening.
  • The interaction between GRIM-19 and Stat3 was confirmed in various cell types and shown to be specific for Stat3.
  • GRIM-19 co-localizes with Stat3 in the perinuclear region, inhibiting Stat3 nuclear translocation stimulated by epidermal growth factor (EGF).
  • GRIM-19 represses Stat3 transcriptional activity, target gene expression, and suppresses cell growth in cancer cells.

Conclusions:

  • GRIM-19 is a novel negative regulator of Signal transducer and activator of transcription 3 (Stat3).
  • The GRIM-19/Stat3 interaction offers a potential therapeutic target for Stat3-driven cancers.
  • Understanding GRIM-19's role provides new insights into cancer cell growth and survival pathways.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...